Table 5.

Anti-inflammatory Potential of H. arbainense extract via SFE1 and SFE2 at Different doses

Dose (µg/g)	Inhibition of protein denaturation (%)			HSD (5%)
	SFE2	SFE1	Diclofenac sodium
0.0	0.00 ± 0.00	0.00 ± 0.00	0.00 ± 0.00	0.00
1.56	34.0 ± 1.36b	25.0 ± 1.01c	41.1 ± 1.03a	4.36
3.125	43.8 ± 2.32b	35.4 ± 0.96c	50.8 ± 1.25a	3.89
6.25	51.9 ± 1.65b	45.3 ± 2.32c	61.2 ± 1.36a	6.49
12.5	61.2 ± 3.32b	53.3 ± 1.85c	71.0 ± 0.94a	5.85
25	70.5 ± 0.66b	62.9 ± 0.56c	81.2 ± 1.52a	3.78
50	77.4 ± 1.02b	71.7 ± 1.26c	88.1 ± 1.31a	2.89
100	83.5 ± 2.32b	81.4 ± 1.63b	92.4 ± 1.16a	3.84
200	90.7 ± 1.97ab	88.8 ± 1.02b	95.8 ± 0.65a	4.65
IC50 (µg/g)	5.29 ± 0.32b	9.63 ± 1.04a	2.55 ± 0.84c	1.98

Data represent means ± standard error (n = 3). Significant differences (P ≤ 0.05) are indicated by different lowercase letters in the same column.